How TikTok Changed Video Advertising Forever?<\/a><\/strong><\/p>\nOwning a business brand isn\u2019t all required to make it big in the business world \u2013 it\u2019s just the first step. To achieve business growth, you\u2019d have to invest in activities that improve the quality of your products and services and make potential buyers aware that you have what they need.<\/p>\n","protected":false},"excerpt":{"rendered":"
Sanofi and GSK have today signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19 vaccine, beginning in 2021. \u201cToday\u2019s announcement showcases our unwavering commitment to develop a COVID-19 vaccine that is available to everyone when it comes to market,\u201d\u00a0said Thomas Triomphe, Executive Vice President […]<\/p>\n","protected":false},"author":3,"featured_media":72866,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_newsletter_tier_id":0,"jetpack_publicize_message":"","jetpack_is_tweetstorm":false,"jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false}}},"categories":[15198,5],"tags":[26063],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Sanofi-and-GSK-sign-agreements-with-the-Government-of-Canada-to-supply-up-to-72-million-doses-of-adjuvanted-COVID-19-vaccine-Brandspurng.jpg?fit=1880%2C1250&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/p8rAyM-iXf","jetpack-related-posts":[{"id":70926,"url":"https:\/\/brandspurng.com\/2020\/09\/03\/sanofi-and-gsk-initiate-phase-1-2-clinical-trial-of-covid-19-adjuvanted-recombinant-protein-based-vaccine-candidate\/","url_meta":{"origin":72865,"position":0},"title":"Sanofi and GSK initiate Phase 1\/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate","author":"Esan Bolaji","date":"September 3, 2020","format":false,"excerpt":"Sanofi and GSK today started the Phase 1\/2 clinical trial for their adjuvanted COVID-19 vaccine. The vaccine candidate, developed in partnership by Sanofi and GSK, uses the same recombinant protein-based technology as one of Sanofi\u2019s seasonal influenza vaccines with GSK\u2019s established pandemic adjuvant technology. The Phase 1\/2 clinical trial is\u2026","rel":"","context":"In "Brand News"","block_context":{"text":"Brand News","link":"https:\/\/brandspurng.com\/category\/brand-news\/"},"img":{"alt_text":"COVID-19 vaccine, vaccine, Sanofi , GSK, clinical trial of COVID-19 vaccine","src":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Vaccine.jpg?fit=400%2C320&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":90695,"url":"https:\/\/brandspurng.com\/2021\/05\/17\/sanofi-and-gsk-covid-19-vaccine-candidate-demonstrates-strong-immune-responses-across-all-adult-age-groups\/","url_meta":{"origin":72865,"position":1},"title":"Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups","author":"Esan Bolaji","date":"May 17, 2021","format":false,"excerpt":"May\u00a017,\u00a02021\u00a0\u2013\u00a0The Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate\u00a0achieved\u00a0strong\u00a0rates of\u00a0neutralizing antibody responses, in line with\u00a0those measured in people who have recovered from COVID-19,\u00a0in all adult age groups in a Phase 2 study\u00a0with 722\u00a0volunteers. A global pivotal Phase 3 study is expected to start in\u00a0the coming weeks. The Phase 2 interim\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/brandspurng.com\/category\/health\/"},"img":{"alt_text":"African Countries Look Beyond West for Vaccines brandspurng","src":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2021\/02\/African-Countries-Look-Beyond-West-for-Vaccines-brandspurng.jpg?fit=1200%2C800&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2021\/02\/African-Countries-Look-Beyond-West-for-Vaccines-brandspurng.jpg?fit=1200%2C800&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2021\/02\/African-Countries-Look-Beyond-West-for-Vaccines-brandspurng.jpg?fit=1200%2C800&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2021\/02\/African-Countries-Look-Beyond-West-for-Vaccines-brandspurng.jpg?fit=1200%2C800&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2021\/02\/African-Countries-Look-Beyond-West-for-Vaccines-brandspurng.jpg?fit=1200%2C800&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":63238,"url":"https:\/\/brandspurng.com\/2020\/04\/15\/sanofi-and-gsk-to-join-forces-in-unprecedented-caccine-collaboration-to-fight-covid-19\/","url_meta":{"origin":72865,"position":2},"title":"Sanofi And GSK To Join Forces In Unprecedented Caccine Collaboration To Fight COVID-19","author":"Brand Spur","date":"April 15, 2020","format":false,"excerpt":"Sanofi and GSK today announce that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic.\u00a0 Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA technology. This technology has produced\u2026","rel":"","context":"In "Brand News"","block_context":{"text":"Brand News","link":"https:\/\/brandspurng.com\/category\/brand-news\/"},"img":{"alt_text":"Sanofi delivers strong 2019 business EPS growth of 6.8% at CER Brandspurng","src":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/02\/Sanofi-delivers-strong-2019-business-EPS-growth-of-6.8-at-CER-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/02\/Sanofi-delivers-strong-2019-business-EPS-growth-of-6.8-at-CER-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/02\/Sanofi-delivers-strong-2019-business-EPS-growth-of-6.8-at-CER-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/02\/Sanofi-delivers-strong-2019-business-EPS-growth-of-6.8-at-CER-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/02\/Sanofi-delivers-strong-2019-business-EPS-growth-of-6.8-at-CER-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":80841,"url":"https:\/\/brandspurng.com\/2020\/12\/11\/sanofi-and-gsk-suffers-major-setback-in-the-development-of-a-covid-19-vaccine\/","url_meta":{"origin":72865,"position":3},"title":"Sanofi and GSK suffers major setback in the development of a Covid-19 vaccine","author":"Esan Bolaji","date":"December 11, 2020","format":false,"excerpt":"December 11, 2020\u00a0\u2013 Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults. Phase 1\/2 study interim results showed an immune response comparable to patients who recovered from COVID-19 in adults aged 18 to 49 years, but a low\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/brandspurng.com\/category\/health\/"},"img":{"alt_text":"Sanofi and GSK suffers major setback in the development of a Covid-19 vaccine bRANDSPURNG","src":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":96508,"url":"https:\/\/brandspurng.com\/2021\/07\/30\/sanofi-sales-grew-double-digit-to-e8-7-billion\/","url_meta":{"origin":72865,"position":4},"title":"Sanofi Sales Grew Double-Digit To \u20ac8.7 Billion","author":"Brand Spur","date":"July 30, 2021","format":false,"excerpt":"Sanofi Q2 2021 sales grew double-digit to \u20ac8.7 billion (up 12.4% at CER) mainly driven by Dupixent\u00ae\u00a0and Vaccines as indicated in its financial result ended June 30, 2021. Specialty Care sales increased 22.0%, due to strong Dupixent\u00ae\u00a0(+56.6%) and new oncology Vaccines up 16.2%, driven by meningitis and boosters franchise recovery;\u2026","rel":"","context":"In "Brand News"","block_context":{"text":"Brand News","link":"https:\/\/brandspurng.com\/category\/brand-news\/"},"img":{"alt_text":"Sanofi and GSK suffers major setback in the development of a Covid-19 vaccine bRANDSPURNG","src":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":93441,"url":"https:\/\/brandspurng.com\/2021\/06\/21\/covid-19-deepens-merchandise-trade-deficit\/","url_meta":{"origin":72865,"position":5},"title":"COVID-19 Deepens Merchandise Trade Deficit","author":"Vetiva Research","date":"June 21, 2021","format":false,"excerpt":"According to the National Bureau of Statistics (NBS), Nigeria recorded higher trade volumes in the first quarter of the year (+7.0% q\/q; +14.1% y\/y). This represents the highest quarterly trade flows (Q1\u201921: \u20a69.8 trillion) Nigeria has recorded since the pandemic disrupted global supply chains (Q1\u201920: \u20a68.5 trillion). While the recovery\u2026","rel":"","context":"In "Business & Economy"","block_context":{"text":"Business & Economy","link":"https:\/\/brandspurng.com\/category\/business-economy\/"},"img":{"alt_text":"Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine","src":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Sanofi-and-GSK-sign-agreements-with-the-Government-of-Canada-to-supply-up-to-72-million-doses-of-adjuvanted-COVID-19-vaccine-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Sanofi-and-GSK-sign-agreements-with-the-Government-of-Canada-to-supply-up-to-72-million-doses-of-adjuvanted-COVID-19-vaccine-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Sanofi-and-GSK-sign-agreements-with-the-Government-of-Canada-to-supply-up-to-72-million-doses-of-adjuvanted-COVID-19-vaccine-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Sanofi-and-GSK-sign-agreements-with-the-Government-of-Canada-to-supply-up-to-72-million-doses-of-adjuvanted-COVID-19-vaccine-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Sanofi-and-GSK-sign-agreements-with-the-Government-of-Canada-to-supply-up-to-72-million-doses-of-adjuvanted-COVID-19-vaccine-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=1050%2C600 3x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/posts\/72865"}],"collection":[{"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/comments?post=72865"}],"version-history":[{"count":0,"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/posts\/72865\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/media\/72866"}],"wp:attachment":[{"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/media?parent=72865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/categories?post=72865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/tags?post=72865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}